Investing in Asia Pacific’s Biotech: Uncovering the Secrets to Investment Successes and Opportunities in the Face of Global Financial Uncertainties

The Asia Pacific (APAC) region has become an increasingly attractive location for investments in recent years. Venture capital investments in Southeast Asia hit a record US$20.4 billion in deal value in 2021, which was 85% higher than the previous peak of US$11 billion in 2018, and a 35% increase compared to 2019 and 2020 combined. According to PitchBook data, Singapore attracted the highest VC funding per capita in the world, raking in a total of $4.1 billion in venture capital investment in 2022.

The panel discussion will feature prominent industry leaders who will share their success stories and investment strategies in APAC's biotech industry. Attendees will discover how to leverage the unique strengths and opportunities of this region for investments, including partnerships, biomanufacturing capabilities, and access to the Asian patient population for clinical trials. This session is tailored to provide valuable insights for seasoned investors or biotech entrepreneurs alike, on the dynamic and promising biotech landscape in the APAC region amidst global financial uncertainties.